Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
A comparative mutation-selection reanalysis of colon and rectal adenocarcinoma highlights PIK3CA variants and BRAF V600E.
Journal: Journal of translational medicine
Published: July 01, 2026
Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 15, 2026
Targeting of Wnt-β-Catenin Pathway in Recurrent Ameloblastoma.
Journal: The New England journal of medicine
Published: June 03, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 01, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 01, 2026
Genomic Landscape and Therapeutic Implications of ALK Fusion-Positive Colorectal Cancer.
Journal: The oncologist
Published: March 10, 2026
ASO Visual Abstract: Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases.
Journal: Annals of surgical oncology
Published: February 24, 2026
PIK3CA Mutations in Early-Onset Appendiceal Adenocarcinoma.
Journal: JCO precision oncology
Published: February 19, 2026
ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases.
Journal: Annals of surgical oncology
Published: February 03, 2026
Efficacy and Safety of the PD-1 Agonist JNJ-67484703 in Participants with Atopic Dermatitis: Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial Results.
Journal: Dermatology and therapy
Published: January 14, 2026
Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials.
Journal: JCO clinical cancer informatics
Published: January 09, 2026
Evolving therapeutics in colorectal cancer peritoneal metastases.
Journal: Cancer metastasis reviews
Published: December 15, 2025
Last Updated: 09/26/2026